Insider Transactions in Q4 2021 at Anaptysbio, Inc (ANAB)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
36,645
-13.12%
|
$1,282,575
$35.68 P/Share
|
|
Dec 20
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,645
+25.83%
|
$36,645
$1.12 P/Share
|
|
Nov 15
2021
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
964
+50.0%
|
$21,208
$22.03 P/Share
|
|
Nov 15
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
523
+50.0%
|
$11,506
$22.03 P/Share
|
|
Nov 15
2021
|
Hamza Suria President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
964
+1.39%
|
$21,208
$22.03 P/Share
|
|
Nov 15
2021
|
Paul F. Lizzul Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
964
+50.0%
|
$21,208
$22.03 P/Share
|
|
Nov 05
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
14,302
-17.45%
|
$500,570
$35.0 P/Share
|
|
Nov 05
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,302
+14.86%
|
$14,302
$1.12 P/Share
|
|
Nov 04
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$175,000
$35.0 P/Share
|
|
Nov 04
2021
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+41.67%
|
$85,000
$17.09 P/Share
|
|
Nov 04
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
6,059
-8.22%
|
$212,065
$35.0 P/Share
|
|
Nov 04
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,059
+7.6%
|
$6,059
$1.12 P/Share
|
|
Nov 01
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
36,646
-18.17%
|
$1,172,672
$32.58 P/Share
|
|
Nov 01
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,646
+26.0%
|
$36,646
$1.12 P/Share
|
|
Oct 26
2021
|
Hamza Suria President, CEO |
SELL
Open market or private sale
|
Direct |
15,993
-19.12%
|
$479,790
$30.0 P/Share
|
|
Oct 26
2021
|
Hamza Suria President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,993
+16.05%
|
$15,993
$1.12 P/Share
|